Transfected, nonsteroidogenic COS-1 cells derived from monkey kidney are found to be capable of supporting the initial and rate-limiting step common to all steroidogenic pathways, the side-chain cleavage of cholesterol to produce pregnenolone. Endogenous COS-1 kidney cell renodoxin reductase and renodoxin are able to sustain low levels of this activity catalyzed by bovine cholesterol side-chain cleavage cytochrome P450 (P450w) whose synthesis is directed by a transfected plasmid containing P450. cDNA. Double transfection with both P450w and adrenodoxin plasmids leads to greater pregnenolone production and indicates that adrenodoxin plays a role as a substrate for this reaction or that bovine adrenodoxin serves as a better electron donor than the endogenous iron-sulfur protein renodoxin. Also it is found that both the bovine adrenodoxin and P450, precursor proteins are proteolytically processed upon their uptake by COS-1 cell mitochondria to forms having the same electrophoretic mobility as mature bovine adrenodoxin and P450s. Following triple transfection of COS-1 cells with P450., adrenodoxin, and 17a-hydroxylase cytochrome P450 plasmids, pregnenolone produced in mitochondria by the side-chain cleavage reaction can be further metabolized in the endoplasmic reticulum to 17a-hydroxypregnenolone and dehydroepiandrosterone. Although this functional steroidogenic pathway can be incorporated into this nonsteroidogenic cell type, it is found to be nonresponsive to cAMP, a potent activator of steroid hormone biosynthesis in adrenal cortex, testis, and ovary. Thus the cellular mechanisms necessary to support both microsomal and mitochondrial steroid hydroxylase activities appear not to be tissue specific, whereas the acute cAMPdependent regulation of steroidogenesis is not present in transformed kidney (COS-1) cells.
ity as mature bovine adrenodoxin and P450s. Following triple transfection of COS-1 cells with P450., adrenodoxin, and 17a-hydroxylase cytochrome P450 plasmids, pregnenolone produced in mitochondria by the side-chain cleavage reaction can be further metabolized in the endoplasmic reticulum to 17a-hydroxypregnenolone and dehydroepiandrosterone. Although this functional steroidogenic pathway can be incorporated into this nonsteroidogenic cell type, it is found to be nonresponsive to cAMP, a potent activator of steroid hormone biosynthesis in adrenal cortex, testis, and ovary. Thus the cellular mechanisms necessary to support both microsomal and mitochondrial steroid hydroxylase activities appear not to be tissue specific, whereas the acute cAMPdependent regulation of steroidogenesis is not present in transformed kidney (COS-1) cells.
In each of the steroidogenic pathways leading to production of glucocorticoids, mineralocorticoids, or sex hormones, the initial step is the side-chain cleavage of cholesterol to yield pregnenolone, a mitochondrial reaction that is rate-limiting due to the regulation of cholesterol availability (1) . Cholesterol side-chain cleavage is catalyzed by a three component enzyme complex consisting of cholesterol side-chain cleavage cytochrome P450 [P450SC, the product of the P45OXXII gene (2) ], an iron-sulfur protein (adrenodoxin), and a flavoprotein (adrenodoxin reductase). In the adrenal cortex this reaction serves as the first step in the production of glucocorticoids, mineralocorticoids, and C19-steroids (the socalled adrenal androgens). In the gonads, this reaction serves as the initial step in the production of the sex hormones testosterone and estrogen as well as the progesterone produced in large quantities by the corpus luteum following ovulation. In the placenta this reaction serves as the initial step in the production of progesterone, and, in some species, of estrogen. In the present study we have examined whether this tissue-specific activity can be expressed in a nonsteroidogenic cell type by transfecting COS-1 cells of monkey kidney origin (3) steroids. This system would appear to be ideal for sitedirected mutagenesis aimed at elucidation of structure-function relationships of both mitochondrial and microsomal steroid hydroxylases. In addition it is evident from these studies that whereas nonsteroidogenic transformed cells have the capacity to support steroidogenic reactions, they lack the cAMP-dependent factors that are key elements in normal regulation of steroidogenesis.
MATERIALS AND METHODS Cloning, identification, and characterization of pCD vectors containing cDNA inserts specific for bovine P450SCC (7), P45017a (8) , and adrenodoxin (9) have been described. The P450scc vector used in this study contains a full-length cDNA insert that was identified and characterized by David Light (Genentech) with the partial-length clone (7) supplied by this laboratory. The amino acid coding sequence deduced from this clone is identical to that described by Morohashi et al.
Proc. Natl. Acad. Sci. USA 85 (1988) (10) . COS-1 cells were obtained from Y. Gluzman (Cold Spring Harbor Laboratory) and were cultured and passaged as described (6) . Transfection of COS-1 cells with a single plasmid was also performed as described (6) , whereas simultaneous transfection with more than one plasmid utilized the same procedure except that the plasmids were mixed together before transfection.
Immunofluorescence studies of transfected COS-1 cells were carried out as described (6) with antibodies specific to bovine adrenodoxin and P450ScC prepared in this laboratory (11) . Antibodies specific for F1-ATPase were kindly provided by Gail Breen (University of Texas at Dallas). Immunoblot analysis of adrenodoxin and P450SCC was carried out as described (12) In steroidogenic cells, P450SCC and adrenodoxin are mitochondrial enzymes encoded by nuclear genes. Both proteins are synthesized in the cytoplasm as higher molecular weight precursors that are proteolytically processed to their mature forms upon uptake by mitochondria (16, 17) . By using in vitro assays consisting of isolated mitochondria and proteins synthesized in a cell-free rabbit reticulocyte lysate translation system, it has been shown that mitochondria from bovine steroidogenic tissues (adrenal cortex and corpus was carried out on coverslips in multiwell dishes (6) by using 10 ,ug of pCDP-450-1OA, a plasmid containing the complete amino acid coding sequence of the bovine P450SCC precursor. Immunofluorescence of P450,SC was performed by using rabbit IgG specific for bovine adrenal P450S
as primary antibody and rhodamine-conjugated goat antibody to rabbit IgG as second antibody. Immunofluorescence of F1-ATPase was performed by using rabbit IgG specific for bovine heart F1-ATPase as primary antibody and fluorescein-conjugated goat antibody to rabbit IgG as the second antibody. (16, 18) . However, in in vitro assays using mitochondria from nonsteroidogenic bovine tissues (heart, liver, and kidney) only the adrenodoxin precursor is taken up and processed, while the P450SCC precursor is refractory to such maturation events (16) . As can be seen by immunoblot analysis (Fig. 2) , bovine P450SCC, following transfection of COS-1 cells with the P450SCC plasmid, is identical in size to P450SCC observed in bovine adrenocortical cells (the mature form). The P450SCC cDNA insert in the pCD vector used for transfection contains the nucleotide sequence encoding the 39-amino acid P450SCC precursor sequence (10) , yet only the mature form is observed in COS-1 cells. Likewise in Fig. 3 it is seen that the mature form of adrenodoxin (12 kDa) predominates in COS-1 cells transfected with the adrenodoxin plasmid, although a small amount of the precursor (19 kDa) is detectable. Thus the precursor forms of bovine P450SCC and bovine adrenodoxin are processed in situ in COS-1 cells to forms that are the same size as their respective mature forms in bovine steroidogenic tissues. The inability of bovine kidney mitochondria to process the P450SCC precursor in vitro (16) when monkey kidney COS-1 cell mitochondria can support this maturation event in situ (this study) is unexplained. In another laboratory, it had been observed (19) that the bovine P450SCC precursor could not be processed by rat heart mitochondria but could be processed by rat liver mitochondria. Perhaps these variations in processing arise from species differences; although in the comparison of P450SCC
processing by bovine and monkey kidney mitochondria, we cannot rule out the possibility that in vitro processing may differ from in situ processing in COS-1 cells. The in situ studies described herein give no information concerning the efficiency of uptake of P450SCC into kidney mitochondria.
These studies utilize a single cell type (COS-1) whereas the in vitro studies utilized mitochondria from whole kidney cortex. It is apparent, however, as opposed to our conjecture (16) , that at least some mitochondria from nonsteroidogenic tissues do contain the capacity to import and process steroidogenic precursors (ref. 19 and this study). Whether the proteolytic cleavage of the adrenodoxin and P450SCC precursors occurs between the correct amino acids in COS-1 cells is not known, although the resultant mature forms are of similar size upon electrophoresis to those in bovine adrenocortical cells. Also it can be noted whereas no detectable P450SCC is found in untransfected COS-1 cells (Fig. 2 cells using the antibody to bovine adrenodoxin (Fig. 3) . This endogenous pattern is identical to that observed in bovine kidney tissue and the lower band of this doublet has been postulated to be the endogenous kidney renodoxin, which is closely related structurally to adrenodoxin (20) .
Not only were the precursor forms of P450,,C and adrenodoxin processed in situ in COS-1 cells but they were also found to be enzymatically active. Using COS-1 cells transfected with the P450sC pCD vector alone, pregnenolone production was detectable after a 10-hr incubation with (22R)-hydroxycholesterol as substrate (data not shown) and reached a level z7 times above background (nontransfected cells) after a 24-hr incubation (Table 1) . This modest cholesterol side-chain cleavage activity is apparently supported by endogenous COS-1 renodoxin reductase and renodoxin, proteins that normally support la-hydroxylation of 25- hydroxyvitamin D in kidney mitochondria. The ability of this kidney electron transport system to support adrenal steroid hydroxylation (P450SCC or 11p-hydroxylase cytochrome P450) has not been studied in detail. In contrast pregnenolone production is much higher in COS-1 cells transfected with both P450SCC and adrenodoxin pCD vectors (Table 1) .
Also the more adrenodoxin plasmid used, the greater the side-chain cleavage activity, up to 10 ,g of plasmid. Perhaps after double transfection with 10 ,ug of each plasmid, the limiting component of this heterologous cholesterol sidechain cleavage complex is the endogenous flavoprotein 
P450j
, both being required for this activity.
Following transfection of COS-1 cells with 10 Ag of adredhodoxin plasmid and 10 ,ug of P450SCC plasmid and inctbltion for 24 hr with (22R)-hydroxycholesterol, the cultute medium was incubated with Pseudomonas testeronii 3f3-hydroxysteroid dehydrogenase (21) , and the products were analyzed by HPLC. Greater than 95% of the product was prbgesterone indicating little or no subsequent metabolism of pregnenolone in these COS-1 cells. However, when triple tfansfection was carried out with the P450SCC, adrenodoxhi, and P45017a pCD vectors, 17a-hydroxypregnenolone and dehydroepiandrosterone were observed as products in addition to pregnenolone (Table 2 ). This result indicates that pregnenolone produced in mitochondria of COS-1 cells can translocate to the endoplasriic reticulum where it is further metabolized by P45017a. We have reported (6) that bovine P45017a in transfected COS-1 cells can catalyze steroid 17a-hydroxylase and steroid C-17,20-lyase activities leading to the production of 17a-hydroxypregnenolone and dehydroepiandrosterone, respectively, from exogenous pregnenolone (6) . From the present studies it is apparent that pregnenolone produced endogenously within transfected COS-1 cells can also be converted to these products. Steroidogenesis in the adrenal cortex and the gonads is regulated by cAMP in response to peptide hormones binding to specific cell-surface receptors (22) . As noted in Table 3 (23) . As shown in Fig. 4 , SCP2, a protein thought to be essential for transport of cholesterol to the mitochondrion in steroidogenic tissues (24) , is present in COS-1 cells. While the level of SCP2 in COS-1 cells is much less than found in bovine adrenocortical cells, it is not very different from that found in human fetal adrenal cells, a very active steroidogenic tissue. Therefore, we imagine that the missing cAMP-responsive elements in monkey kidney cells act prior to and/or subsequent to the transport of cholesterol to the mitochondria. Potential candidates for such factors missing in nonsteroidogenic cells would include cholesterol ester hydrolase (25) and the so-called "cycloheximide-sensitive factor" (26) . Clearly the cAMP-mediated mobilization of cholesterol to the inner mitochondrial membrane is tissue-specific and serves a key regulatory role in steroidogenesis; for example, in adrenal cells leading to the rapid production of glucocorticoids in response to stress, the "fight or flight" response.
In summary, by transfection of nonsteroidogenic COS-1 cells with plasmids containing cDNA sequences for steroid hydroxylases we have been able to model several steps, both mitochondrial and microsomal, in the steroidogenic pathway leading from C27 steroids to C19 steroids. Thus, a number of steps required in the processing of these transcripts, including cleavage of precursor sequences, insertion into mitochondria or endoplasmic reticulum, introduction of heme and iron-sulfur prosthetic groups, can be accomplished by these nonsteroidogenic cells. By contrast, these studies indicate that the acute mobilization ofcholesterol in steroidogenesis is a tissue-specific event as is, of course, the expression of steroid hydroxylase genes. Also it is apparent from these studies that site-directed mutagenesis of 
